DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response (Q42982593)

12 November 2017

title

DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response (English)

1 reference

12 November 2017

0 references

1 reference

5

H J Alter

1 reference

12 November 2017

X Jiao

1

1 reference

12 November 2017

R Y-H Wang

2

1 reference

12 November 2017

Z Feng

3

1 reference

12 November 2017

G Hu

4

1 reference

12 November 2017

J W -K Shih

6

1 reference

12 November 2017

publication date

1 January 2004

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

11

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

18-26

1 reference

The scientific challenge of hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

The role of hepatitis C virus specific CD4 T lymphocytes in acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Humoral and CD4( ) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8 T cell immunogenicity and protective efficacy in the influenza and malaria models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

21 January 2018

Th1/Th2 cross regulation

1 reference

https://api.crossref.org/works/10.1046/J.1352-0504.2003.00464.X

Cellular immune response to the hepatitis C virus

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Lymphokine production by human T cells in disease states

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1352-0504.2003.00464.X

Identifiers

DOI

10.1046/J.1352-0504.2003.00464.X

1 reference

12 November 2017

1 reference